Inventor · disambiguated record
Fred H. Mermelstein
Also filed as: MERMELSTEIN FRED · MERMELSTEIN FRED H
9 granted patents·20 pending applications·125 citations·filing 1998–2025
87Inventor score
Files withPOLARX BIOPHARMACEUTICALS INC5WRIGHT CURTIS4CHOLLET JANET A3INNOVATIVE DRUG DELIVERY SYSTE3WEG STUART L3
Top patents by PatentIndex Score
29 records- 0189US7273889B2NMDA receptor antagonist formulation with reduced neurotoxicityINNOVATIVE DRUG DELIVERY SYSTE·Filed 2002·Granted Sep 25, 2007·82 cites·4 claims
- 0284US8946292B2Formulations of low dose diclofenac and beta-cyclodextrinWRIGHT CURTIS·Filed 2011·Granted Feb 3, 2015·6 cites·5 claims
- 0382US8580954B2Formulations of low dose diclofenac and beta-cyclodextrinWRIGHT CURTIS·Filed 2007·Granted Nov 12, 2013·4 cites·4 claims
- 0479US6875451B2Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compoundsPOLARX BIOPHARMACEUTICALS INC·Filed 1998·Granted Apr 5, 2005·32 cites·11 claims
- 0565US2022054435A1Nmda receptor antagonist formulation with reduced neurotoxicityWEG STUART L·Filed 2021·Application pending·0 cites
- 0663US9480662B1Compositions and methods for topical tamoxifen citrate therapyCHOLLET JANET A·Filed 2015·Granted Nov 1, 2016·1 cites·8 claims
- 0761US2015105467A1Formulations of low dose diclofenac and beta-cyclodextrinJAVELIN PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0858US2014107209A1Formulations of low dose diclofenac and beta-cyclodextrinWRIGHT CURTIS·Filed 2013·Application pending·0 cites
- 0957US2014171514A1Nmda receptor antagonist formulation with reduced neurotoxicitySTUART L WEG·Filed 2014·Application pending·0 cites
- 1057US2008041367A1NMDA Receptor Antagonist Formulation With Reduced NeurotoxicityMERMELSTEIN FRED H·Filed 2007·Application pending·0 cites
- 1155US7163703B2Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compoundsPOLARX BIOPHARMACEUTICALS INC·Filed 2003·Granted Jan 16, 2007·0 cites·10 claims
- 1255US7132116B2Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compoundsPOLARX BIOPHARMACEUTICALS INC·Filed 2003·Granted Nov 7, 2006·0 cites·11 claims
- 1355US2004197420A1Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compoundsPOLARX BIOPHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1455US2004197421A1Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compoundsPOLARX BIOPHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1554US2024118283A1Engineered microorganisms for detection of diseased cellsMICROBIAL MACHINES INC·Filed 2023·Application pending·0 cites
- 1654US2007264309A1Method Of Treating Atrophic VaginitisCHOLLET JANET A·Filed 2007·Application pending·0 cites
- 1753US2008221144A1Controlled Release FormulationsINNOVATIVE DRUG DELIVERY SYSTE·Filed 2008·Application pending·0 cites
- 1850US2025297220A1Immune-activating complexesDYNAMIC CELL THERAPIES INC·Filed 2025·Application pending·0 cites
- 1950US2004138298A1NMDA receptor antagonist formulation with reduced neurotoxicityINNOVATIVE DRUG DELIVERY SYSTE·Filed 2003·Application pending·0 cites
- 2049US2005175679A1Controlled release formulationsFiled 2004·Application pending·0 cites
- 2148US2016175266A1Nmda receptor antagonist formulation with reduced neurotoxicityWEG STUART L·Filed 2016·Application pending·0 cites
- 2246US9675546B2Method of treating atrophic vaginitisKLAMERUS BERNADETTE·Filed 2008·Granted Jun 13, 2017·0 cites·31 claims
- 2346US2006111284A1Method for treating cancerYURKOW EDWARD J·Filed 2003·Application pending·0 cites
- 2445US9693953B2Method of treating atrophic vaginitisCHOLLET JANET A·Filed 2007·Granted Jul 4, 2017·0 cites·15 claims
- 2545US2016000733A1Nmda receptor antagonist formulation with reduced neurotoxicityWEG STUART L·Filed 2015·Application pending·0 cites
- 2645US2007232567A1Formulations Of Low Dose Non-Steroidal Anti-Inflammatory Drugs And Beta-CyclodextrinWRIGHT CURTIS·Filed 2007·Application pending·0 cites
- 2744US2023320591A1Engineering microorganisms for diagnostic imagingMICROBIAL MACHINES INC·Filed 2021·Application pending·0 cites
- 2844US2003036513A1Method for treating cancerFiled 2002·Application pending·0 cites
- 2936US2013102948A1Portable blood filtration devices, systems, and methodsREICH ILAN K·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fred H. Mermelstein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →